CAESAREA, Israel, Nov. 19, 2018 /PRNewswire/ -- Mazor Robotics Ltd.
(TASE: MZOR; NASDAQGM: MZOR), a pioneer and a leader in the field
of robotic guidance systems, today announced that at a Special
General Meeting of Shareholders held earlier today, Mazor Robotics
shareholders approved the previously announced definitive merger
agreement with wholly-owned subsidiaries of Medtronic plc (NYSE:
MDT).
Approximately 53 percent of Mazor Robotics ordinary shares were
represented in the meeting. Approximately 95 percent of the shares
represented in the meeting which are neither held by a Medtronic
affiliated party nor by a controlling shareholder of the Company or
a shareholder with a personal interest in the merger proposal, were
cast in favor of the merger.
Upon completion of the transaction, Mazor Robotics shareholders
will receive $58.50 per American
Depository Share, or $29.25 per
ordinary share, in cash, for a total of approximately $1.64 billion. The transaction remains subject to
certain closing conditions and is expected to close during
Medtronic's third fiscal quarter ending January 25, 2019.
About Mazor
Mazor Robotics (TASE: MZOR; NASDAQGM: MZOR) believes in healing
through innovation by developing and introducing revolutionary
technologies and products aimed at redefining the gold standard of
quality care. Mazor Robotics Guidance System enables surgeons to
conduct spine and brain procedures in an accurate and secure
manner. For more information, please visit
www.MazorRobotics.com.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
and other securities laws. Any statements in this release about
future expectations, plans or prospects for the Company, including
without limitation, statements regarding the acquisition of Mazor,
including the expected timing of the closing of the transaction,
and other statements containing the words "believes,"
"anticipates," "plans," "expects," "will" and similar expressions
are forward-looking statements. These statements are only
predictions based on Mazor's current expectations and projections
about future events. There are important factors that could cause
Mazor's actual results, level of activity, performance or
achievements to differ materially from the results, level of
activity, performance or achievements expressed or implied by the
forward-looking statements. Those factors include, but are not
limited to, the impact of general economic conditions, competitive
products, product demand and market acceptance risks, reliance on
key strategic alliances, fluctuations in operating results, and
other factors indicated in Mazor's filings with the Securities and
Exchange Commission (SEC) including those discussed under the
heading "Risk Factors" in Mazor's annual report on Form 20-F filed
with the SEC on April 30, 2018 and in
subsequent filings with the SEC. For more details, refer to Mazor's
SEC filings. Mazor undertakes no obligation to update
forward-looking statements to reflect subsequent occurring events
or circumstances, or to changes in our expectations, except as may
be required by law.
U.S. Contacts: EVC Group
Michael Polyviou/Doug
Sherk- Investors
mpolyviou@evcgroup.com; dsherk@evcgroup.com
732-933-2754; 415-652-9100
View original
content:http://www.prnewswire.com/news-releases/mazor-robotics-shareholders-approve-merger-agreement-with-medtronic-300753308.html
SOURCE Mazor Robotics Ltd.